BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 37445827)

  • 1. Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease.
    Molière S; Jaulin A; Tomasetto CL; Dali-Youcef N
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
    Reynolds JJ
    Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013-2023).
    Almutairi S; Kalloush HM; Manoon NA; Bardaweel SK
    Molecules; 2023 Jul; 28(14):. PubMed ID: 37513440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and periodontal diseases.
    Sapna G; Gokul S; Bagri-Manjrekar K
    Oral Dis; 2014 Sep; 20(6):538-50. PubMed ID: 23849049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and their inhibitors in gastric cancer.
    Murray GI; Duncan ME; Arbuckle E; Melvin WT; Fothergill JE
    Gut; 1998 Dec; 43(6):791-7. PubMed ID: 9824606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases: their potential role in the pathogenesis of diabetic nephropathy.
    Thrailkill KM; Clay Bunn R; Fowlkes JL
    Endocrine; 2009 Feb; 35(1):1-10. PubMed ID: 18972226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in joint tissues of rapidly destructive coxarthropathy (RDC), analyzed by immunohistochemical study].
    Matsumoto F; Uzuki M; Kaneko C; Rikimaru A; Kokubun S; Sawai T
    Ryumachi; 1997 Oct; 37(5):688-95. PubMed ID: 9396371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
    Matsunaga Y; Koda M; Murawaki Y
    Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.
    Radisky ES; Raeeszadeh-Sarmazdeh M; Radisky DC
    J Cell Biochem; 2017 Nov; 118(11):3531-3548. PubMed ID: 28585723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G; Walter I; Helmreich M; Egerbacher M
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy.
    Riley SC; Leask R; Chard T; Wathen NC; Calder AA; Howe DC
    Mol Hum Reprod; 1999 Apr; 5(4):376-81. PubMed ID: 10321811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional role of invariant water molecules in matrix metalloproteinases: a data-mining approach.
    Kumar H; Mandal SK; Gogoi P; Kanaujia SP
    J Biomol Struct Dyn; 2022; 40(20):10074-10085. PubMed ID: 34121627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional and temporal changes in the synthesis of matrix metalloproteinases and TIMP-1 during development of the rabbit mandibular condyle.
    Breckon JJ; Hembry RM; Reynolds JJ; Meikle MC
    J Anat; 1994 Feb; 184 ( Pt 1)(Pt 1):99-110. PubMed ID: 8157496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.
    Knittel T; Mehde M; Grundmann A; Saile B; Scharf JG; Ramadori G
    Histochem Cell Biol; 2000 Jun; 113(6):443-53. PubMed ID: 10933221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.